IT-DIAB

Active principles, namely, active chemical ingredients used in manufacturing pharmaceuticals for treating type II diabetes, prediabetes and their acute or chronic complications

Pharmaceutical preparations and substances, preparations for medical use, for the preventive and curative treatment of type II diabetes, of prediabetes and their acute or chronic complications; Preparations, products and devices for medical use, in particular, diagnostic biomarkers and cellular models for the in vivo, ex vivo or in vitro diagnosis of type II diabetes, of prediabetes and their associated acute or chronic complications; Preparations, products and devices, in particular, diagnostic biomarkers and cellular models for the medical follow-up of patients at risk or of patients suffering from type II diabetes, prediabetes and their associated acute or chronic complications; Preparations, products and devices in particular diagnostic biomarkers and cellular models for the selection and assessment of drugs and their compounds for their preventive and curative properties towards type II diabetes, prediabetes and their associated acute or chronic complications

Electronic databases and computer programs for retrieving, compiling, integrating and sending data relating to research on type II diabetes, prediabetes and their associated acute or chronic complications in particular experimental data concerning the targets, biomarkers, cellular models and animal testing models which are being used or developed; Electronic databases and computer programs for retrieving, compiling, integrating and sending data relating to methods for the preventive or curative treatment of type II diabetes, of prediabetes and their acute or chronic complications; Electronic databases and computer programs for retrieving, compiling, integrating and sending medical data relating to the condition of patients monitored for the preventive or curative treatment of type II diabetes, of prediabetes and their acute or chronic complications

Scientific research in the field of prevention, diagnosis, screening, preventive or curative treatment of type II diabetes, of prediabetes and their acute or chronic complications; Scientific research, in particular clinical research on the assessment of the effects of drugs and their compounds having preventive or curative properties of type II diabetes, prediabetes and their acute or chronic complications; Development and validation of tests for the diagnosis and medical follow-up of patients at risk or of patients suffering from type II diabetes, prediabetes and their associated acute or chronic complications; Development and validation of biological tests in vitro, ex vivo and in vivo for sorting and selecting compounds, products and substances intended for the preventive or curative treatment of type II diabetes, prediabetes and their associated acute or chronic complications